Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling

Type 1 angiotensin receptors (AT) are G-protein coupled receptors, mediating the physiological actions of the vasoactive peptide angiotensin II. In this study, the roles of 7 amino acids of the rat AT receptor in ligand binding and signaling were investigated by performing functional assays of individual receptor mutants expressed in COS and Chinese hamster ovary cells. Substitutions of polar residues in the third transmembrane domain with Ala indicate that Ser, Ser, and Ser are not essential for maintenance of the angiotensin II binding site. Replacement of Asn or Ser does not alter the binding affinity for peptidic analogs, but modifies the ability of the receptor to interact with AT (DuP753)- or AT (CGP42112A)-specific ligands. These 2 residues are probably involved in determining the binding specificity for these analogs. The absence of G-protein coupling to the Ser mutant suggests that this residue, in addition to previously identified residues, Asp and Tyr, participates in the receptor activation mechanism. Finally, Lys (third helix) and Lys (fifth helix) mutants do not bind angiotensin II or different analogs. Co-expression of these two deficient receptors permitted the restoration of a normal binding site. This effect was not due to homologous recombination of the cDNAs but to protein trans-complementation.

[1]  M. Caron,et al.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.

[2]  H. Inui,et al.  Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. , 1993, The Journal of biological chemistry.

[3]  P. Timmermans,et al.  Identification of angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[4]  Yue Zhang,et al.  Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan. , 1994, The Journal of biological chemistry.

[5]  R. Farese,et al.  Rapid effects of angiotensin-II on polyphosphoinositide metabolism in the rat adrenal glomerulosa. , 1984, Endocrinology.

[6]  W. Rutter,et al.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose , 1986, Cell.

[7]  N. Iwai,et al.  Identification of two subtypes in the rat type I angiotensin II receptor , 1992, FEBS letters.

[8]  B. Maigret,et al.  Tyr292 in the seventh transmembrane domain of the AT1A angiotensin II receptor is essential for its coupling to phospholipase C. , 1994, The Journal of biological chemistry.

[9]  C. Strader,et al.  Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.

[10]  W. Greenlee,et al.  Identification of peptide binding residues in the extracellular domains of the AT1 receptor. , 1994, The Journal of biological chemistry.

[11]  P. Corvol,et al.  Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Corvol,et al.  Internalization of the rat AT1a and AT1b receptors: pharmacological and functional requirements , 1994, FEBS letters.

[13]  S. Chaki,et al.  Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. , 1992, Biochemical and biophysical research communications.

[14]  M. Gershengorn,et al.  Thyrotropin-releasing hormone (TRH) receptor number determines the size of the TRH-responsive phosphoinositide pool. Demonstration using controlled expression of TRH receptors by adenovirus mediated gene transfer. , 1994, The Journal of biological chemistry.

[15]  P. Corvol,et al.  Synthetic cDNA encoding the rat AT1a receptor: a useful tool for structure-function relationship analysis. , 1994, Biochemical and biophysical research communications.

[16]  H. Sasamura,et al.  Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors , 1995, The Journal of biological chemistry.

[17]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[18]  K Prendergast,et al.  Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor. , 1994, Chemistry & biology.

[19]  S. Whitebread,et al.  Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[20]  J. Glowinski,et al.  Tachykinin Receptors of the NK1 Type (Substance P) Coupled Positively to Phospholipase C on Cortical Astrocytes from the Newborn Mouse in Primary Culture , 1989, Journal of neurochemistry.

[21]  P. Timmermans,et al.  Angiotensin II receptors and angiotensin II receptor antagonists. , 1993, Pharmacological reviews.

[22]  B. Kobilka,et al.  Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. , 1992, Biochemical and biophysical research communications.

[23]  J. Wess,et al.  Reconstitution of functional muscarinic receptors by co‐expression of amino‐ and carboxyl‐terminal receptor fragments , 1993, FEBS letters.

[24]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Alexander,et al.  A recombinant rat vascular AT1 receptor confers growth properties to angiotensin II in Chinese hamster ovary cells. , 1992, Biochemical and biophysical research communications.

[26]  M. Thibonnier,et al.  Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. , 1994, The Journal of biological chemistry.

[27]  J. Murray,et al.  Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor , 1991, Nature.

[28]  T. Schwartz,et al.  Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  U. Steckelings,et al.  Angiotensin II Receptor Subtypes: Characterization, Signalling Mechanisms, and Possible Physiological Implications , 1993, Frontiers in Neuroendocrinology.

[30]  Michael J. Berridge,et al.  Inositol phosphates and cell signalling , 1989, Nature.

[31]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[32]  R. Alexander,et al.  Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor , 1991, Nature.

[33]  T. Lorca,et al.  Deglycosylation and fragmentation of purified rat liver angiotensin II receptor: application to the mapping of hormone-binding domains. , 1993, The Biochemical journal.